Cargando…
Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models
Copper carbosilane metallodendrimers containing chloride ligands and nitrate ligands were mixed with commercially available conventional anticancer drugs, doxorubicin, methotrexate and 5-fluorouracil, for a possible therapeutic system. To verify the hypothesis that copper metallodendrimers can form...
Autores principales: | Hołota, Marcin, Michlewska, Sylwia, Garcia-Gallego, Sandra, del Olmo, Natalia Sanz, Ortega, Paula, Bryszewska, Maria, de la Mata, Francisco Javier, Ionov, Maksim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960994/ https://www.ncbi.nlm.nih.gov/pubmed/36835489 http://dx.doi.org/10.3390/ijms24044076 |
Ejemplares similares
-
In Vitro Anticancer Properties of Copper Metallodendrimers
por: Hołota, Marcin, et al.
Publicado: (2019) -
Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells
por: Sanz del Olmo, Natalia, et al.
Publicado: (2020) -
Insight on the Structure-to-Activity of Carbosilane Metallodendrimers in the Fight against Staphylococcus aureus Biofilms
por: Llamazares, Celia, et al.
Publicado: (2021) -
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells
por: Michlewska, Sylwia, et al.
Publicado: (2020) -
Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug
por: Michlewska, Sylwia, et al.
Publicado: (2019)